Clinical Research & Clinical Trial Management | Project Owner

R emoving duplication in clinical trial operations could significantly reduce costs and increase research capacity.  One emerging technology that may help enable this transformation is the concept of AI agents . But what exactly are AI agents, and how could they improve clinical trial operations? What are AI agents? An AI agent is a software system designed to perform tasks autonomously based on defined goals, available data, and operational rules . Traditional software typically executes predefined commands. AI agents, in contrast, can interpret information, analyze context, and trigger actions within complex workflows. In practical terms, AI agents can: interpret structured information coordinate operational processes trigger workflows across systems monitor data and identify anomalies generate reports or documentation Rather than acting only as databases or static tools, AI agents can function as digital operators that help coordinate processes ...

Is cross-system clinical trial automation failing not because workflows cannot be executed, but because protocol terminology cannot be interpreted consistently across systems and clinical studies? Discussions about automating clinical trials often focus on advanced technologies such as workflow engines, interoperability standards, and AI/ML. In practice, cross-system automation most often breaks much earlier, at a far more basic level: inconsistent naming conventions .  Clinical protocols are written in natural language, where the same term can legitimately carry different meanings depending on study design, therapeutic area, or regulatory intent. Software systems, by contrast, assume that identifiers are stable, explicit, and unambiguous. This mismatch creates friction long before questions of execution logic or governance arise. Several academic and industry initiatives have proposed encoding protocol elements, such as eligibility criteria, visits, milestones, consen...